Abstract:BACKGROUNDThe gastric microbiota in patients with gastric cancer (GC) has received increasing attention, but the profiling of the gastric microbiome through the histological stages of gastric tumorigenesis remains poorly understood, especially for patients with Helicobacter pylori-negative GC (HPNGC).AIMTo characterize microbial profiles of gastric mucosa and juice for HPNGC carcinogenesis and identify distinct taxa in precancerous lesions.METHODSThe 16S rRNA gene analysis was performed on gastric mucosa from 134 Helicobacter pylori-negative cases, including 56 superficial gastritis (SG), 9 atrophic gastritis (AG), 27 intestinal metaplasia (IM), 29 dysplasia (Dys), and 13 GC cases, to investigate differences in gastric microbial diversity and composition across the disease stages. In addition, paired gastric mucosa and juice samples from 18 SG, 18 IM, and 18 Dys samples were analyzed. alpha-Diversity was measured by Shannon and Chao1 indexes, and beta-diversity was calculated using partial least squares discrimination analysis (PLS-DA). Differences in the microbial composition across disease stages in different sample types were assessed using the linear discriminant analysis effect size.RESULTSThe diversity and composition of the bacterial microbiota in the gastric mucosa changed progressively across stages of gastric carcinogenesis. The diversity of the gastric mucosa microbiota was found to be significantly lower in the IM and Dys groups than in the SG group, and the patients with GC had the lowest bacterial community richness (P < 0.05). Patients with IM and those with Dys had similar gastric mucosa microbiota profiles with Ralstonia and Rhodococcus as the predominant genera. Microbial network analysis showed that there was increasing correlation strength between IM and Dys (|correlation threshold|& GE; 0.5, P < 0.05). GC and its precancerous lesions have distinguishable bacterial taxa; our results identified HPNGC-associated bacteria Streptococcaceae and Lactobacillaceae (P < 0.05). Additionally, across precancerous lesion stages from AG to Dys in Helicobacter pylori-negative patients, Burkholderiaceae abundance continuously increased, while Streptococcaceae and Prevotellaceae abundance presented a continuous downward trend. Furthermore, the microbial diversity was higher in gastric juice (P < 0.001) than in the mucosa, while PLS-DA revealed a statistically significant difference between the two groups (ANOSIM, P = 0.001). A significant difference in the microbial structure was identified, with Proteobacteria being more prevalent in the gastric mucosa and Firmicutes being more abundant in gastric juice.CONCLUSIONOur results provide insights into potential taxonomic biomarkers for HPNGC and its precancerous stages and assist in predicting the prognosis of IM and Dys based on the mucosal microbiota profile.

Variations of cellular membrane phospholipids with genesis of gastric cancer

[Variations of cellular membrane phospholipids with genesis and hepatic metastasis of large intestine cancer]

Study on lipid change in gastric cancer and the analysis of gastric cancer cell membrane phospholipid variation

[Cell membrane phospholipid variation and protein kinase C expression effects on hepatic metastasis of large intestinal carcinoma]

Serum phospholipids are potential biomarkers for the early diagnosis of gastric cancer

Plasma lipids signify the progression of precancerous gastric lesions to gastric cancer: a prospective targeted lipidomics study

Small molecules as potential biomarkers of early gastric cancer: A mass spectrometry imaging approach

Alterations of Gastric Mucosal Microbiota Across Different Stomach Microhabitats in a Cohort of 276 Patients with Gastric Cancer

Genetic polymorphism of the phospholipase C epsilon 1 gene and risk of gastric cancer.

Overexpression of Lysophosphatidylcholine Acyltransferase 1 and Concomitant Lipid Alterations in Gastric Cancer

Plasma Membrane Proteomic Analysis of Human Gastric Cancer Tissues: Revealing Flotillin 1 As a Marker for Gastric Cancer

A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter Pylori Antibodies, and Gastric Cancer Risk.

Alterations in bacterial community dynamics from noncancerous to Gastric cancer

Proteomic and serological markers for diagnosing cardia gastric cancer and precursor lesions in a Chinese population

Microbiome Changes in the Gastric Mucosa and Gastric Juice in Different Histological Stages of Helicobacter Pylori-Negative Gastric Cancers

[Proliferative Changes of Human Gastric Mucosa Cells in Different Pathological Lesions and Their Clinical Significance].

Identification of Phosphatidylcholine and Lysophosphatidylcholine As Novel Biomarkers for Cervical Cancers in a Prospective Cohort Study

Integrative Analysis of the Proteome and Transcriptome in Gastric Cancer Identified LRP1B As a Potential Biomarker

Differential Expression of Phospholipase C Epsilon 1 is Associated with Chronic Atrophic Gastritis and Gastric Cancer

Gastrointestinal Microbiota Changes in Patients With Gastric Precancerous Lesions

[The Relation Between Helicobacter Pylori Infection and P53 Mutation, MG-7 Antigen and AgNORs Expression in the Development of Gastric Mucosa Lesions].